secwatch / observer

8-K filed March 25, 2025, 7:59 PM ET ticker ALLR CIK 0001860657

other material confidence high sentiment neutral materiality 0.50

Allarity Therapeutics engages ShareIntel to investigate potential illegal naked short selling

Allarity Therapeutics, Inc.

Engaged Shareholder Intelligence Services (ShareIntel) to probe potential illegal naked short selling and trading irregularities.
Will use ShareIntel's DRIL-Down™ platform to analyze trading data from broker-dealers and clearing firms.
CEO Thomas Jensen cites investor inquiries and notable stock volatility as drivers for the investigation.
If violations of SEC Regulation SHO are found, Allarity will consider legal recourse against responsible parties.
Investigation aims to protect shareholder value as the company advances clinical development of stenoparib.

item 8.01 item 9.01

Allarity Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-009132

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.